Advertisement
Advertisement
U.S. markets close in 1 hour 59 minutes
Advertisement
Advertisement
Advertisement
Advertisement

InterCure Ltd. (INCR-U.TO)

Toronto - Toronto Real Time Price. Currency in USD
3.72000.0000 (0.00%)
As of 09:30AM EST. Market open.
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
Previous Close3.7200
Open3.7200
Bid3.6700 x N/A
Ask3.8100 x N/A
Day's Range3.7200 - 3.7200
52 Week Range3.3500 - 8.0000
Volume85
Avg. Volume266
Market Cap169.53M
Beta (5Y Monthly)-0.21
PE Ratio (TTM)16.91
EPS (TTM)0.2200
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for INCR-U.TO

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • GlobeNewswire

      InterCure Announces Exclusive International Partnership Agreement with Award Winning Cannabis Brand "Binske"

      Leading Global Pharmaceutical Cannabis Company, InterCure, entered into an agreement with Praetorian Global, Inc. to license, manufacture and distribute the Florida-based cannabis brand ”Binske”NEW YORK and TORONTO and HERZLIYA, Israel, Dec. 19, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), the largest and fastest growing medical cannabis company outside of North America, today announced that it has entered into a

    • GlobeNewswire

      InterCure to Participate in Cowen 5th Annual Cannabis Conference

      Mr. Rabinovitch is one of the global cannabis senior executives to participateNEW YORK and TORONTO and HERZLIYA, Israel, Dec. 08, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that Alexander Rabinovitch, CEO of InterCure, will participate in Cowen 5th Annual Cannabis Conference, taking place December 8th, 2022. Mr. Rabinovitch will take part in the industry leaders panel on Thursday, December 8th, 202

    • GlobeNewswire

      InterCure Announces the Withdrawal of a Class Action Lawsuit against it

      NEW YORK and TORONTO and HERZLIYA, Israel, Dec. 05, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company") is pleased to announce the withdrawal of a class action lawsuit against it (the “Regenera Lawsuit”). The Regenera Lawsuit was described in the Company’s press release dated May 26, 2020 and in the Company's most recent Annual Report and Annual Information Form and it was primarily concerning a motion to certify, as a cl

    Advertisement
    Advertisement